Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (15)

« Back to Publications

Tumor-targeted glycogen nanoparticles loaded with hemin and glucose oxidase to promote tumor synergistic therapy.

Qiu L. et al, (2023), Int J Biol Macromol, 239

Comparison of different methods for isolating CD8+ T lymphocyte-derived extracellular vesicles and supramolecular attack particles.

Jainarayanan AK. et al, (2023), J Extracell Biol, 2

Engineered bacteria combined with doxorubicin nanoparticles suppress angiogenesis and metastasis in murine melanoma models.

Yang M. et al, (2023), Acta Biomater, 158, 734 - 746

Author Correction: GAPDH controls extracellular vesicle biogenesis and enhances the therapeutic potential of EV mediated siRNA delivery to the brain.

Dar GH. et al, (2021), Nat Commun, 12

GAPDH controls extracellular vesicle biogenesis and enhances the therapeutic potential of EV mediated siRNA delivery to the brain.

Dar GH. et al, (2021), Nat Commun, 12

Amelioration of systemic inflammation via the display of two different decoy protein receptors on extracellular vesicles.

Gupta D. et al, (2021), Nat Biomed Eng, 5, 1084 - 1098

Gene therapy with AR isoform 2 rescues spinal and bulbar muscular atrophy phenotype by modulating AR transcriptional activity.

Lim WF. et al, (2021), Sci Adv, 7

Profiling of Extracellular Small RNAs Highlights a Strong Bias towards Non-Vesicular Secretion.

Sork H. et al, (2021), Cells, 10

Engineered extracellular vesicle decoy receptor-mediated modulation of the IL6 trans-signalling pathway in muscle.

Conceição M. et al, (2021), Biomaterials, 266

Gene therapies for polyglutamine diseases

Matos C. et al, (2020)

Extracellular microRNAs exhibit sequence-dependent stability and cellular release kinetics.

Coenen-Stass AML. et al, (2019), RNA Biol, 16, 696 - 706

Safety profile of the intravenous administration of brain-targeted stable nucleic acid lipid particles.

Conceição M. et al, (2016), Data Brief, 6, 700 - 705

Intravenous administration of brain-targeted stable nucleic acid lipid particles alleviates Machado-Joseph disease neurological phenotype.

Conceição M. et al, (2016), Biomaterials, 82, 124 - 137

Overexpression of mutant ataxin-3 in mouse cerebellum induces ataxia and cerebellar neuropathology.

Nóbrega C. et al, (2013), Cerebellum, 12, 441 - 455

Tumor-targeted Chlorotoxin-coupled Nanoparticles for Nucleic Acid Delivery to Glioblastoma Cells: A Promising System for Glioblastoma Treatment.

Costa PM. et al, (2013), Mol Ther Nucleic Acids, 2